FDA approves Medtronic’s heart mapping system

Minneapolis-based Medtronic earned clearance from the Food and Drug Administration for its CardioInsight Noninvasive 3-D Mapping System.

Advertisement

While cardiac mapping typically involves clinicians inserting a catherter into a patient’s heart via an artery or vein, the CardioInisght system relies on a 252-electrode sensor vest worn by the patient to retrieve the same electrical data in the heart.

The system provides electroanatomic 3-D maps of the heart and can identify a wide range of irregular heart rhythms in the upper and lower chambers, according to a news release.

To view an animation of the CardioInsight System in use, click here.

More articles on suply chain:

Shifting drug production back to US could raise prices: 5 takeaways
Mayo Clinic physician: A stripped down FDA would be ‘chaotic’
Bard Peripheral Vascular recalls Halo One guiding sheath

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.